About
Jerrold F. Rosenbaum, MD, is affiliated with the Center for the Neuroscience of Psychedelics at Massachusetts General Hospital and the Department of Psychiatry at Harvard Medical School. His publications, spanning from 1997 to 2024, focus on major depressive disorder, panic disorder, anxiety, posttraumatic stress disorder, and the clinical use of psychedelics. He has contributed to research on antidepressant trial design, treatment updates for depression subtypes, and the clinical management of benzodiazepines in anxiety disorders. His frequent collaborators include Andrew A. Nierenberg, Maurizio Fava, and Jonathan E. Alpert.
